Dr Stella Blackburn, VP, Global Head of Early Access & Risk Management, Real World Evidence Solutions at IQVIA
Dr Blackburn studied medicine at Cambridge and Guys and worked in hospital medicine before joining the pharmaceutical industry. She has worked in pharmacovigilance and pharmacoepidemiology for 30 years: in industry (11+ years) as a regulator (nearly 17 years) and CRO (3+ years). She has an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine. In 1997 she joined the European Medicines Agency (EMA). Dr Blackburn developed EU strategy and policy on risk management, writing the EU guidelines on this topic and was part of the core team implementing the 2010 PhV legislation. She was on original steering group developing ENCEPP and was the Alternate Co-ordinator, and a scientific work package leader, of IMI PROTECT.
Dr Blackburn is a Fellow of the International Society of Pharmacoepidemiology, the Royal College of Physicians of Edinburgh and the Faculty of Pharmaceutical Medicine. She is a past President of ISPE and an Honorary Associate Professor at the LSHTM and Visiting Scientist at MIT.
Prof Kaichun Wu, Chief Professor, Dept of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi’an, China
Dr Kaichun Wu is a professor and the Deputy Chair of Xijing Hospital of Digestive Diseases, The Fourth Military Medical University. He received his MD and PhD degrees from the Fourth Military Medical University, and research experience in Oxford University (UK), Nottingham University (UK) and Northwestern University (USA). He serves as Vice-President of Chinese Society of Gastroenterology (CSG) and internationally Council Member of the World Gastroenterology Organisation (WGO), Co-opted Council Member of the Asia Pacific Association of Gastroenterology (APAGE). Professor Wu has published more than 300 papers in peer-reviewed journals like Gastroenterology, Hepatology, J Hepatol, Oncogene, J Immunol, FASEB J, etc. His research work on gastric cancer has received State First Class Award for Science and Technology in China. Professor Wu has a wide spectrum of research exposure and interest which includes inflammatory bowel disease, gastrointestinal tumors, gastroesophageal reflux disease, gastrointestinal bleeding, etc.
Presentation: Pharmacoepidemiology of prokinetic agents
Prokinetic agents is one of the most commonly used drugs in clinic. Through the past decades, they show promising future in the treatment of gastrointestinal diseases, such as dyspepsia, gastroesophageal reflux disease, constipation and so on. Here, we review the pharmacoepidemiology of some representative drugs, including metoclopramide, domperidone, cisapride, mosapride and itopride. We review their distribution of usage, efficacy in clinical practice, and also pay attention to their safety.